Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02310971 | Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | withdrawn | Phase 2 | 0 | Prima BioMed LtdINDUSTRY | 0 | Apr 3, 2015 | clinicaltrials |
| NCT00411762 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | completed | Phase 1 / Phase 2 | 25 | Yale UniversityOTHER | 1 | Mar 27, 2015 | clinicaltrials |
| NCT01130701 | A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .(PMABIIS) | withdrawn | Phase 2 | 0 | University of Massachusetts, WorcesterOTHER | 1 | Mar 17, 2015 | clinicaltrials |
| NCT01472198 | A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma | completed | Phase 2 | 250 | Gilead SciencesINDUSTRY | 2 | Mar 10, 2015 | clinicaltrials |
| NCT01608841 | The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib | unknown | Phase 2 | 88 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Feb 18, 2015 | clinicaltrials |
| NCT00652366 | A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 467 | Hoffmann-La RocheINDUSTRY | 23 | Feb 11, 2015 | clinicaltrials |
| NCT01898741 | Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 30 | UMC UtrechtOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT01628458 | Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer(RFA of LAPC) | completed | Phase 2 | 17 | UMC UtrechtOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT02351219 | FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer(FLAP) | completed | Phase 2 | 50 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Jan 30, 2015 | clinicaltrials |
| NCT00114244 | Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2015 | clinicaltrials |
| NCT00785421 | Chemotherapy With or Without Enoxaparin in Pancreatic Cancer(PROSPECT) | completed | Phase 2 / Phase 3 | 312 | CONKO-StudiengruppeOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT00962312 | Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 9 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | unknown | Phase 2 / Phase 3 | 1 | Assiut UniversityOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01232829 | Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer | completed | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Nov 26, 2014 | clinicaltrials |
| NCT00131911 | Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors | completed | Phase 2 | 93 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01593995 | EGF Ointment for Erlotinib Skin Lesion | completed | Phase 2 | 52 | Dong-A University HospitalOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT00482625 | Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Oct 16, 2014 | clinicaltrials |
| NCT00185588 | Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 33 | George Albert FisherOTHER | 1 | Sep 15, 2014 | clinicaltrials |
| NCT00003769 | Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer | completed | Phase 2 | — | Indiana UniversityOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT00372944 | AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy | completed | Phase 2 | 70 | AstraZenecaINDUSTRY | 5 | Aug 13, 2014 | clinicaltrials |
| NCT00409292 | RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 33 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01339754 | Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy(PACT-18) | completed | Phase 2 | 25 | IRCCS San RaffaeleOTHER | 1 | Aug 11, 2014 | clinicaltrials |
| NCT00577889 | Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jul 25, 2014 | clinicaltrials |
| NCT01227018 | PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer | terminated | Phase 2 | 15 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00225784 | Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer | completed | Phase 2 | 37 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Jul 16, 2014 | clinicaltrials |
| NCT00837876 | Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 37 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00331682 | Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer | completed | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00002955 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | 21 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00003085 | Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer | terminated | Phase 2 | 28 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00305877 | Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery | completed | Phase 2 | 137 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT02135822 | Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer(NAPGAP) | unknown | Phase 2 | 30 | Chinese PLA General HospitalOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT00091026 | Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 143 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT01020006 | Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine | completed | Phase 2 | 42 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 24, 2014 | clinicaltrials |
| NCT01124786 | A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) | completed | Phase 2 | 367 | Clovis Oncology, Inc.INDUSTRY | 15 | Apr 17, 2014 | clinicaltrials |
| NCT00203892 | Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma | completed | Phase 1 / Phase 2 | 23 | University of ChicagoOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01505413 | Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer(GEMOX-T) | completed | Phase 2 | 33 | Soonchunhyang University HospitalOTHER | 1 | Apr 3, 2014 | clinicaltrials |
| NCT02098291 | An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma(PC1) | completed | Phase 2 | 34 | Cancer Advances Inc.INDUSTRY | 0 | Mar 28, 2014 | clinicaltrials |
| NCT02098239 | Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. | completed | Phase 2 | 41 | Cancer Advances Inc.INDUSTRY | 0 | Mar 27, 2014 | clinicaltrials |
| NCT01065870 | Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) | unknown | Phase 2 / Phase 3 | 64 | Columbia UniversityOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00553813 | A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer | terminated | Phase 2 | 23 | Cortice Biosciences, Inc.INDUSTRY | 2 | Jan 22, 2014 | clinicaltrials |
| NCT00636883 | Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer(GEMOX-T) | terminated | Phase 2 | 9 | National Guard Health AffairsOTHER_GOV | 1 | Jan 22, 2014 | clinicaltrials |
| NCT01074996 | Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers(APC-S1) | unknown | Phase 2 | 92 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01941342 | Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy | unknown | Phase 2 | 274 | Southwest Hospital, ChinaOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01096732 | Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)(HIPPoS) | terminated | Phase 2 | 3 | Lisa BaxOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00613730 | Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint(APPRISE 1) | terminated | Phase 2 | 3 | AmgenINDUSTRY | 0 | Jan 6, 2014 | clinicaltrials |
| NCT00003780 | Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | unknown | Phase 2 | 150 | Meyer PharmaceuticalsINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003797 | Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas | unknown | Phase 2 | 41 | Brown UniversityOTHER | 1 | Dec 19, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 3, 2015source: clinicaltrials